Comprehensive Immigration Guidance for Extraordinary Ability, Outstanding Researchers, and Multinational Executives
The EB-1 is an employment-based immigrant visa that allows highly accomplished individuals, leading researchers, and multinational executives or managers to obtain permanent residency in the United States.
Unlike many employment-based visas, certain EB-1 categories allow individuals to self-petition, while others require sponsorship from a U.S. employer.
Eligibility depends on the specific EB-1 category:

Evidence development and documentation

Eligibility assessment and case strategy

Employer coordination (if required)

Petition preparation and filing

Guidance on adjustment of status or consular processing
To qualify, you must be a national of a treaty country and invest a substantial amount of capital in a U.S. business. The business must be an active commercial enterprise generating more than enough income to support the investor and their family.
The E-2 visa itself does not lead directly to a green card, but you can explore options like the EB-5 Investor Program or family- or employment-based green cards.
The E-2 visa is typically granted for an initial period of 2 to 5 years and can be renewed indefinitely, as long as the business continues to meet visa requirements.
Yes! Spouses and unmarried children under 21 can accompany the E-2 investor. Spouses receive an open work authorization (can work for any employer), and children can attend school in the U.S.
The law doesn’t specify a minimum, but your investment must be sufficient to ensure the successful operation of your business. Generally, $80,000–$100,000 is considered a good starting point.
To maintain your E-2 status, your business must remain active and operational. A temporary decline in revenue or profitability should not affect your visa status. In the case that you decide to seize all operations of your business- you would need to consider other immigration options.
For Individuals Seeking Permanent Residency, Understand your eligibility for EB-1 classification and the strongest path forward.